article thumbnail

Parkinson’s UK calls on government to mark World Patient Safety Day

PharmaTimes

The report outlines ways the government can help patients with Parkinson’s disease - News - PharmaTimes

article thumbnail

Pfizer, BioNTech enter $3.2bn deal with US government for Covid-19 shots

Pharmaceutical Technology

Pfizer and BioNTech have entered a new vaccine supply agreement worth $3.2bn with the US government to supply further doses of their Covid-19 vaccine. As per the agreement, the government will procure 105 million 3µg, 10 µg and 30 µg doses of the vaccine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Navigating the Regulatory Environment of Pharmaceutical Marketing: Balancing Patient Safety and Industry Innovation

Pharma Marketing Network

In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation. First, it is important to understand the different regulatory agencies that govern pharmaceutical marketing.

Safety 52
article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. How can this be mitigated?

article thumbnail

MHRA publishes strategy on AI regulation

European Pharmaceutical Review

It summarises the MHRA’s view on the UK government’s white paper on AI regulation published in 2023. Following publication of this white paper, the government requested that the MHRA outline the steps the agency is working on in relation to its expectations.

Safety 59
article thumbnail

Covid vaccine profits and the strain on supply channels

World of DTC Marketing

At the time, pharmaceutical giant Pfizer and its partner BioNTech—which now have the other US-authorized COVID-19 vaccine—had inked a deal with the US government to supply doses at $19.50 Also, Johnson & Johnson had a deal to supply the US government with doses of its vaccine—still in the works—at a rate of $10 per dose.

article thumbnail

US eyes link between Pfizer bivalent COVID jab and stroke

pharmaphorum

. “Although the totality of the data currently suggests that it is very unlikely that the signal…represents a true clinical risk, we believe it is important to share this information with the public, as we have in the past, when one of our safety monitoring systems detects a signal,” said the statement. 1 variant of Omicron.

Safety 104